Ninety-five percent of patients with advanced cancer have an insufficient understanding of their prognosis and are ill-equipped to make informed end-of-life care decisions, according to a study by Holly Prigerson, Ph.D., and colleagues. Read more
A simple blood test may better predict which patients diagnosed with liver cancer will experience disease recurrence, according to new research from Weill Cornell Medicine doctors. Read more
The tumor microenvironment can determine whether cancer cells become aggressive cancer stem cells that are resistant to treatment and cause cancers to come back after therapy, according to a new study by a team of researchers led by Shahin Rafii. Read more
Researchers at Weill Cornell Medicine and the Cornell University College of Veterinary Medicine have undertaken an ambitious $5 million project to create new model systems that accurately reflect the biology, genetics and tumor-host interactions of difficult-to-treat blood cancers. Read more
Thousands of hematologists gathered in San Diego on Dec. 3 for the 58th Annual Meeting of the American Society of Hematology (ASH), and Weill Cornell Medicine/NewYork-Presbyterian was well represented. Read more
Infectious complication rates following prostate biopsies continue to increase, despite decreased use of the procedures, according to Jim Hu, M.D. Read more
A multidisciplinary team led by Ithaca member Mingming Wu has devised a method for measuring the force a breast cancer cell exerts on its fibrous surroundings. Read more
Lipstick Angels, a non-profit that brings volunteer makeup artists into hospitals to treat them with facials, makeovers and massage treatments has started a program at NewYork-Presbyterian. Read more